{"id":3353,"date":"2026-08-31T15:25:07","date_gmt":"2026-08-31T14:25:07","guid":{"rendered":"https:\/\/seamlessbio.de\/?p=3353"},"modified":"2026-08-31T15:25:09","modified_gmt":"2026-08-31T14:25:09","slug":"disease-state-serum-ivdr-cross-reactivity-checklist","status":"publish","type":"post","link":"https:\/\/seamlessbio.de\/de\/disease-state-serum-ivdr-cross-reactivity-checklist\/","title":{"rendered":"Cross-Reactivity"},"content":{"rendered":"<p><!--\nWORDPRESS BLOG POST\nSlug: disease-state-serum-ivdr-cross-reactivity-checklist\nSEO Title: Disease State Serum for IVDR Cross-Reactivity Testing \u2014 Practical Checklist | SeamlessBio\nMeta Description: A practical checklist of disease state serum panels needed for IVDR cross-reactivity and interference testing \u2014 autoimmune, infectious, endocrine, and metabolic conditions.\nFocus Keyword: disease state serum IVDR cross-reactivity testing\nCategory: IVD Development\nTags: IVDR, IVD, disease state serum, human biomaterials, diagnostics\n--><br \/>\n<!-- \nWORDPRESS BLOG POST \u2014 PASTE INTO GUTENBERG\nCategory: IVD Development\nAdd featured image\nInternal links already included in content\n--><\/p>\n<style>\n.sb-blog-post{font-family:-apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,sans-serif;max-width:780px;margin:0 auto;padding:0 0 60px;color:#202020;line-height:1.75}\n.sb-blog-post .sb-lede{font-size:18px;font-weight:500;color:#3a4a50;border-left:4px solid #18b7b2;padding-left:20px;margin:0 0 32px;line-height:1.65}\n.sb-blog-post h2{font-size:24px;font-weight:800;margin:44px 0 14px;color:#111;padding-bottom:10px;border-bottom:2px solid #e2eceb}\n.sb-blog-post h3{font-size:18px;font-weight:700;margin:32px 0 10px;color:#18b7b2}\n.sb-blog-post p{margin:0 0 18px}\n.sb-blog-post ul,.sb-blog-post ol{margin:0 0 18px;padding-left:24px}\n.sb-blog-post li{margin-bottom:8px}\n.sb-blog-post table{width:100%;border-collapse:collapse;font-size:14px;margin:20px 0 28px;overflow-x:auto;display:block}\n.sb-blog-post th{background:#18b7b2;color:#fff;text-align:left;padding:10px 14px;font-weight:700;white-space:nowrap}\n.sb-blog-post td{padding:10px 14px;border-bottom:1px solid #e2eceb;vertical-align:top}\n.sb-blog-post tr:last-child td{border-bottom:none}\n.sb-blog-post td:first-child{font-weight:600;color:#111}\n.sb-blog-post a{color:#18b7b2;text-decoration:none;font-weight:600}\n.sb-blog-post a:hover{text-decoration:underline}\n.sb-blog-post strong{color:#111}\n<\/style>\n<div class=\"sb-blog-post\">\n<p class=\"sb-lede\">Cross-reactivity testing is one of the most under-resourced parts of IVD performance evaluation \u2014 until a Notified Body review flags missing data two weeks before your submission deadline. This post gives you a practical checklist of disease state serum panels commonly required for IVDR performance evaluation, organised by assay type, so you can plan your sourcing timeline correctly.<\/p>\n<h2>Why cross-reactivity testing matters for IVDR<\/h2>\n<p>An IVD that correctly identifies positive and negative samples from healthy donors or confirmed-positive patients does not automatically perform correctly in a clinical population. Patients are rarely single-disease \u2014 they have co-morbidities, concurrent infections, elevated inflammatory markers, unusual antibody profiles, and metabolic disorders that can interact with the assay chemistry to produce false positives or altered quantitative results.<\/p>\n<p>IVDR performance evaluation under EU Regulation 2017\/746 requires demonstration that the device performs as intended in the full range of conditions it will encounter in the intended-use population. For a thyroid assay used in a general clinical laboratory, that population includes patients with autoimmune conditions, lipid disorders, and concurrent infections \u2014 all of which can interfere with immunoassays.<\/p>\n<h2>The general interference panel \u2014 start here<\/h2>\n<p>Before building your disease-specific cross-reactivity panel, every IVD performance evaluation should include a general interference panel covering the most common sources of non-specific interference in immunoassays:<\/p>\n<table>\n<thead>\n<tr>\n<th>Interferent<\/th>\n<th>Mechanismus<\/th>\n<th>Typical level to test<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Rheumatoid Factor (RF)<\/td>\n<td>IgM anti-IgG \u2014 bridges murine capture and detection antibodies in sandwich assays<\/td>\n<td>High positive \u2014 &gt;500 IU\/mL<\/td>\n<\/tr>\n<tr>\n<td>Antinuclear Antibodies (ANA)<\/td>\n<td>Non-specific antibody binding to assay components<\/td>\n<td>ANA positive, titre &gt;1:160<\/td>\n<\/tr>\n<tr>\n<td>HAMA (Human Anti-Mouse Antibodies)<\/td>\n<td>Bridges murine antibodies in sandwich format \u2014 false positive signal<\/td>\n<td>High positive &gt;100 ng\/mL<\/td>\n<\/tr>\n<tr>\n<td>Lipemia<\/td>\n<td>Optical interference, protein binding displacement<\/td>\n<td>Triglycerides &gt;1,000 mg\/dL<\/td>\n<\/tr>\n<tr>\n<td>Icterus (bilirubin)<\/td>\n<td>Optical interference at wavelengths used for detection<\/td>\n<td>Bilirubin &gt;20 mg\/dL<\/td>\n<\/tr>\n<tr>\n<td>Haemolysis<\/td>\n<td>Haemoglobin optical interference, released intracellular enzymes<\/td>\n<td>Haemoglobin &gt;500 mg\/dL<\/td>\n<\/tr>\n<tr>\n<td>Biotin (Vitamin B7)<\/td>\n<td>Competes with biotinylated assay components in streptavidin-biotin based assays<\/td>\n<td>&gt;1,000 ng\/mL \u2014 seen in supplement users<\/td>\n<\/tr>\n<tr>\n<td>Polyclonal hypergammaglobulinaemia<\/td>\n<td>Elevated total IgG causes non-specific background<\/td>\n<td>Total IgG &gt;30 g\/L<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Cross-reactivity checklist by assay type<\/h2>\n<h3>Infectious disease assays (HIV, HBV, HCV)<\/h3>\n<p>Cross-reactivity testing for infectious disease assays is largely defined by the CTS 2009\/108\/EC. Beyond the general interference panel, include:<\/p>\n<ul>\n<li>Co-infections: HIV-positive donors for HBV and HCV assays (and vice versa)<\/li>\n<li>Other hepatitis viruses: HAV, HEV, HDV antibody-positive donors<\/li>\n<li>Herpes virus group: CMV, EBV, HSV-1\/2, VZV antibody-positive<\/li>\n<li>Respiratory pathogens: Influenza A\/B, Mycoplasma pneumoniae, Chlamydia pneumoniae<\/li>\n<li>Sexually transmitted: Syphilis (Treponema pallidum), Chlamydia trachomatis, HSV-2<\/li>\n<li>Tropical: Malaria (Plasmodium antibody and antigen), Toxoplasma gondii, Leishmania<\/li>\n<li>Vaccinated donors: Hepatitis B vaccine, MMR, influenza<\/li>\n<li>Pregnant donors: 100\u2013200 pregnant women (1st, 2nd, 3rd trimester)<\/li>\n<\/ul>\n<h3>Thyroid assays (TSH, fT4, fT3, anti-TPO, TRAb)<\/h3>\n<p>Thyroid assays are among the most interference-prone immunoassays in clinical chemistry. Specific cross-reactivity concerns:<\/p>\n<ul>\n<li>Heterophile antibodies and HAMA \u2014 very common source of TSH false positives<\/li>\n<li>Anti-TPO positive donors \u2014 for TSH and fT4 assays where antibody binding affects free hormone measurement<\/li>\n<li>TRAb positive donors \u2014 for TSH receptor antibody interference in TSH assays<\/li>\n<li>Anti-Tg positive \u2014 for thyroglobulin assay interference testing<\/li>\n<li>Graves&#8217; Disease and Hashimoto&#8217;s patients \u2014 confirmed clinical diagnosis<\/li>\n<li>Pregnancy serum \u2014 TSH suppression in first trimester is physiological; assay must distinguish from pathological suppression<\/li>\n<li>Biotin interference \u2014 particularly important for thyroid assays using streptavidin-biotin platforms (TSH, fT4 on Roche Elecsys)<\/li>\n<\/ul>\n<h3>Autoimmune assays (ANA, anti-CCP, RF, dsDNA)<\/h3>\n<ul>\n<li>Co-existing autoimmune conditions: SLE, Rheumatoid Arthritis, Sj\u00f6gren&#8217;s Syndrome, Myasthenia gravis, Primary Biliary Cholangitis \u2014 overlap syndromes are common<\/li>\n<li>Infectious triggers: Post-infectious ANA positivity \u2014 EBV, CMV, HCV can transiently induce ANA<\/li>\n<li>Age and gender: Elderly female donors have higher baseline ANA positivity rates<\/li>\n<li>Medications: Some drugs (hydralazine, procainamide, isoniazid) induce drug-related lupus with ANA positivity \u2014 medication history should be documented in donor records<\/li>\n<\/ul>\n<h3>Cardiac markers (troponin, BNP, NT-proBNP, CK-MB)<\/h3>\n<ul>\n<li>HAMA \u2014 the most important interferent for troponin assays using murine antibodies<\/li>\n<li>RF \u2014 high RF can bridge murine antibodies producing false positive troponin<\/li>\n<li>Renal failure serum \u2014 elevated creatinine (troponin is renally cleared \u2014 elevated in CKD without cardiac damage)<\/li>\n<li>Skeletal muscle injury: elevated CK-MM and myoglobin can interfere with CK-MB assays<\/li>\n<li>Haemolysis: particularly important for troponin I assays where released haemoglobin interferes<\/li>\n<\/ul>\n<h3>Allergy assays (total IgE, specific IgE)<\/h3>\n<ul>\n<li>Polyclonal hypergammaglobulinaemia \u2014 elevated total immunoglobulins can produce false elevated total IgE<\/li>\n<li>Parasitic infection: Ascaris, Toxocara, Schistosoma infection causes polyclonal IgE elevation mimicking allergy<\/li>\n<li>Atopic dermatitis: very high total IgE (&gt;5,000 IU\/mL) \u2014 assay linearity and hook effect testing<\/li>\n<li>Concurrent autoimmune: IgE deficiency occurs in some autoimmune conditions<\/li>\n<\/ul>\n<h2>Planning your cross-reactivity sourcing timeline<\/h2>\n<p>The most common mistake is treating cross-reactivity panel sourcing as an afterthought \u2014 something to arrange after the main sensitivity\/specificity study is designed. In practice, some materials have long lead times:<\/p>\n<ul>\n<li><strong>Standard panels (RF, ANA, lipemic, icteric, haemolytic):<\/strong> typically available from stock \u2014 1\u20132 weeks<\/li>\n<li><strong>Specific infectious disease positives (malaria, HTLV, leishmania):<\/strong> rare \u2014 4\u20138 weeks lead time<\/li>\n<li><strong>HAMA high positive:<\/strong> uncommon \u2014 2\u20134 weeks<\/li>\n<li><strong>Drug-induced conditions:<\/strong> requires medication documentation \u2014 4\u20138 weeks<\/li>\n<li><strong>Pregnancy cohorts:<\/strong> requires collection coordination \u2014 4\u20138 weeks for trimester-specific<\/li>\n<\/ul>\n<p>Build your cross-reactivity panel sourcing into your study protocol timeline at the same time as your sensitivity\/specificity panels \u2014 not after.<\/p>\n<h2>Practical next steps<\/h2>\n<p>SeamlessBio supplies disease state serum and plasma for IVDR cross-reactivity testing across all major diagnostic areas \u2014 autoimmune, infectious, thyroid, allergy, diabetes, oncology, and drugs of abuse. Materials are native human biomaterial with confirmed diagnostic results, full donor documentation, and IVDR documentation on request.<\/p>\n<ul>\n<li><a href=\"https:\/\/seamlessbio.de\/de\/disease-state-serum-panels\/\">Disease State Serum Panels \u2014 Full Portfolio \u2192<\/a><\/li>\n<li><a href=\"https:\/\/seamlessbio.de\/de\/ivdr-class-d-sample-sets\/\">IVDR Class D Sample Sets \u2192<\/a><\/li>\n<li><a href=\"https:\/\/seamlessbio.de\/de\/human-quality-controls-standard-materials\/\">Quality Controls &#038; Standards \u2192<\/a><\/li>\n<li><a href=\"https:\/\/seamlessbio.de\/de\/what-is-disease-state-serum\/\">What is Disease State Serum? \u2192<\/a><\/li>\n<li><a href=\"https:\/\/seamlessbio.de\/de\/kontakt\/\">Request panels or quote \u2192<\/a><\/li>\n<\/ul>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Cross-reactivity testing is one of the most under-resourced parts of IVD performance evaluation \u2014 until a Notified Body review flags missing data two weeks before your submission deadline. This post [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-3353","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Disease State Serum for IVDR Cross-Reactivity Testing - Checklist<\/title>\n<meta name=\"description\" content=\"A practical checklist of disease state serum panels needed for IVDR cross-reactivity and interference testing \u2014 autoimmune, infectious, endocrine, and metabolic conditions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seamlessbio.de\/de\/disease-state-serum-ivdr-cross-reactivity-checklist\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Disease State Serum for IVDR Cross-Reactivity Testing - Checklist\" \/>\n<meta property=\"og:description\" content=\"A practical checklist of disease state serum panels needed for IVDR cross-reactivity and interference testing \u2014 autoimmune, infectious, endocrine, and metabolic conditions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seamlessbio.de\/de\/disease-state-serum-ivdr-cross-reactivity-checklist\/\" \/>\n<meta property=\"og:site_name\" content=\"SeamlessBio\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-31T14:25:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-31T14:25:09+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/person\\\/cd959a5b0b21c02c26d6ffef79f0d529\"},\"headline\":\"Cross-Reactivity\",\"datePublished\":\"2026-08-31T14:25:07+00:00\",\"dateModified\":\"2026-08-31T14:25:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/\"},\"wordCount\":889,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/\",\"name\":\"Disease State Serum for IVDR Cross-Reactivity Testing - Checklist\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\"},\"datePublished\":\"2026-08-31T14:25:07+00:00\",\"dateModified\":\"2026-08-31T14:25:09+00:00\",\"description\":\"A practical checklist of disease state serum panels needed for IVDR cross-reactivity and interference testing \u2014 autoimmune, infectious, endocrine, and metabolic conditions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"name\":\"SeamlessBio\",\"description\":\"Expert for biological materials for pharma, vaccines and research organizations\",\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seamlessbio.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":[\"Organization\",\"Place\",\"ProfessionalService\"],\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\",\"name\":\"SeamlessBio\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"logo\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/#local-main-organization-logo\"},\"image\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/#local-main-organization-logo\"},\"address\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/#local-main-place-address\"},\"telephone\":[\"+49 (851) 37932226\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+49 (851) 37932226\",\"email\":\"info@seamlessbio.de\"},\"openingHoursSpecification\":[{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\"],\"opens\":\"09:00\",\"closes\":\"17:00\"},{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Saturday\",\"Sunday\"],\"opens\":\"00:00\",\"closes\":\"00:00\"}],\"email\":\"info@seamlessbio.de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/person\\\/cd959a5b0b21c02c26d6ffef79f0d529\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\\\/\\\/seamlessbio.de\"],\"url\":\"https:\\\/\\\/seamlessbio.de\\\/de\\\/author\\\/admin\\\/\"},{\"@type\":\"PostalAddress\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/#local-main-place-address\",\"streetAddress\":\"Dr.-Ernst-Derra-Str. 4\",\"addressLocality\":\"Passau\",\"postalCode\":\"94036\",\"addressRegion\":\"Bavaria\",\"addressCountry\":\"DE\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/disease-state-serum-ivdr-cross-reactivity-checklist\\\/#local-main-organization-logo\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/134428046-2.png\",\"contentUrl\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/134428046-2.png\",\"width\":973,\"height\":288,\"caption\":\"SeamlessBio\"}]}<\/script>\n<meta name=\"geo.placename\" content=\"Passau\" \/>\n<meta name=\"geo.region\" content=\"Deutschland\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Disease State Serum for IVDR Cross-Reactivity Testing - Checklist","description":"A practical checklist of disease state serum panels needed for IVDR cross-reactivity and interference testing \u2014 autoimmune, infectious, endocrine, and metabolic conditions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seamlessbio.de\/de\/disease-state-serum-ivdr-cross-reactivity-checklist\/","og_locale":"de_DE","og_type":"article","og_title":"Disease State Serum for IVDR Cross-Reactivity Testing - Checklist","og_description":"A practical checklist of disease state serum panels needed for IVDR cross-reactivity and interference testing \u2014 autoimmune, infectious, endocrine, and metabolic conditions.","og_url":"https:\/\/seamlessbio.de\/de\/disease-state-serum-ivdr-cross-reactivity-checklist\/","og_site_name":"SeamlessBio","article_published_time":"2026-08-31T14:25:07+00:00","article_modified_time":"2026-08-31T14:25:09+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"admin","Gesch\u00e4tzte Lesezeit":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/#article","isPartOf":{"@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/"},"author":{"name":"admin","@id":"https:\/\/seamlessbio.de\/#\/schema\/person\/cd959a5b0b21c02c26d6ffef79f0d529"},"headline":"Cross-Reactivity","datePublished":"2026-08-31T14:25:07+00:00","dateModified":"2026-08-31T14:25:09+00:00","mainEntityOfPage":{"@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/"},"wordCount":889,"commentCount":0,"publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/","url":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/","name":"Disease State Serum for IVDR Cross-Reactivity Testing - Checklist","isPartOf":{"@id":"https:\/\/seamlessbio.de\/#website"},"datePublished":"2026-08-31T14:25:07+00:00","dateModified":"2026-08-31T14:25:09+00:00","description":"A practical checklist of disease state serum panels needed for IVDR cross-reactivity and interference testing \u2014 autoimmune, infectious, endocrine, and metabolic conditions.","breadcrumb":{"@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/"]}]},{"@type":"WebSite","@id":"https:\/\/seamlessbio.de\/#website","url":"https:\/\/seamlessbio.de\/","name":"SeamlessBio","description":"Experte f\u00fcr biologische Materialien f\u00fcr die Pharmaindustrie, Impfstoffe und Forschungseinrichtungen","publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seamlessbio.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":["Organization","Place","ProfessionalService"],"@id":"https:\/\/seamlessbio.de\/#organization","name":"SeamlessBio","url":"https:\/\/seamlessbio.de\/","logo":{"@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/#local-main-organization-logo"},"image":{"@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/#local-main-organization-logo"},"address":{"@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/#local-main-place-address"},"telephone":["+49 (851) 37932226"],"contactPoint":{"@type":"ContactPoint","telephone":"+49 (851) 37932226","email":"info@seamlessbio.de"},"openingHoursSpecification":[{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday"],"opens":"09:00","closes":"17:00"},{"@type":"OpeningHoursSpecification","dayOfWeek":["Saturday","Sunday"],"opens":"00:00","closes":"00:00"}],"email":"info@seamlessbio.de"},{"@type":"Person","@id":"https:\/\/seamlessbio.de\/#\/schema\/person\/cd959a5b0b21c02c26d6ffef79f0d529","name":"admin","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/seamlessbio.de"],"url":"https:\/\/seamlessbio.de\/de\/author\/admin\/"},{"@type":"PostalAddress","@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/#local-main-place-address","streetAddress":"Dr.-Ernst-Derra-Str. 4","addressLocality":"Passau","postalCode":"94036","addressRegion":"Bavaria","addressCountry":"DE"},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/seamlessbio.de\/disease-state-serum-ivdr-cross-reactivity-checklist\/#local-main-organization-logo","url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046-2.png","contentUrl":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046-2.png","width":973,"height":288,"caption":"SeamlessBio"}]},"geo.placename":"Passau","geo.region":"Deutschland"},"_links":{"self":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/comments?post=3353"}],"version-history":[{"count":1,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3353\/revisions"}],"predecessor-version":[{"id":3354,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3353\/revisions\/3354"}],"wp:attachment":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/media?parent=3353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/categories?post=3353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/tags?post=3353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}